(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -3.80%6.64B | -3.77%13.23B | -2.56%6.9B | 4.08%13.75B | 13.63%7.08B | 13.65%13.21B | 19.44%6.23B | 11.93%11.62B | 5.51%5.22B | 17.88%10.38B |
Operating income | -3.80%6.64B | -3.77%13.23B | -2.56%6.9B | 4.08%13.75B | 13.63%7.08B | 13.65%13.21B | 19.44%6.23B | 11.93%11.62B | 5.51%5.22B | 17.88%10.38B |
Cost of sales | 2.83%-3.26B | -2.25%-6.59B | 0.49%-3.35B | -10.00%-6.44B | -27.93%-3.37B | -14.31%-5.86B | -20.00%-2.63B | -32.37%-5.12B | -21.50%-2.2B | -13.17%-3.87B |
Operating expenses | 2.83%-3.26B | -2.25%-6.59B | 0.49%-3.35B | -10.00%-6.44B | -27.93%-3.37B | -14.31%-5.86B | -20.00%-2.63B | -32.37%-5.12B | -21.50%-2.2B | -13.17%-3.87B |
Gross profit | -4.71%3.38B | -9.07%6.64B | -4.44%3.54B | -0.64%7.31B | 3.15%3.71B | 13.13%7.35B | 19.04%3.59B | -0.22%6.5B | -3.71%3.02B | 20.87%6.51B |
Selling expenses | 4.28%-1.26B | -1.81%-2.58B | -5.04%-1.32B | 5.89%-2.54B | 3.40%-1.26B | -6.56%-2.7B | -9.03%-1.3B | 9.10%-2.53B | 10.20%-1.19B | -14.11%-2.78B |
Administrative expenses | -0.37%-539.77M | -11.35%-1.25B | -1.19%-537.78M | -0.34%-1.12B | 4.10%-531.45M | -2.74%-1.12B | -23.80%-554.17M | -10.31%-1.09B | 6.46%-447.63M | -6.20%-987.21M |
Research and development expenses | -2.40%-301.61M | -6.54%-592.85M | -18.24%-294.56M | -10.61%-556.44M | -20.98%-249.13M | -18.53%-503.08M | -40.26%-205.92M | -4.44%-424.42M | 14.33%-146.82M | -30.59%-406.36M |
Impairment and provision | 36.87%-7.49M | 84.25%-5.34M | 56.41%-11.86M | -31.81%-33.93M | 21.79%-27.22M | 26.96%-25.74M | -53,438.46%-34.8M | -118.05%-35.24M | -100.53%-65K | 9.76%-16.16M |
-Other impairment is provision | 36.87%-7.49M | 84.25%-5.34M | 56.41%-11.86M | -31.81%-33.93M | 21.79%-27.22M | 26.96%-25.74M | -53,438.46%-34.8M | -118.05%-35.24M | -100.53%-65K | 9.76%-16.16M |
Operating interest expense | ---- | ---- | ---- | ---- | -4.20%-71.58M | 21.51%-140.44M | 35.49%-68.7M | 55.04%-178.94M | ---106.48M | ---397.95M |
Special items of operating profit | 10.23%191.38M | -20.87%352.68M | -48.25%173.62M | 5,066.96%445.7M | 293.48%335.52M | -97.25%8.63M | -15.20%85.27M | 26.70%313.44M | 11.69%100.55M | -25.95%247.39M |
Operating profit | -6.28%1.45B | -26.75%2.57B | -18.60%1.55B | 21.67%3.5B | 25.87%1.91B | 12.60%2.88B | 23.61%1.51B | 17.73%2.56B | -2.66%1.23B | 7.15%2.17B |
Financing cost | 6.80%-128.78M | -42.62%-272.97M | ---138.17M | ---191.4M | ---- | ---- | ---- | ---- | ---- | ---- |
Share of profits of associates | -11.13%47.63M | 10.49%86.08M | 33.38%53.6M | --77.91M | 3.03%40.19M | ---- | 42.73%39M | -88.69%9.17M | -22.44%27.33M | 143.93%81.1M |
Share of profit from joint venture company | -709.68%-6.87M | -229.28%-9.22M | 210.07%1.13M | -427.50%-2.8M | ---1.02M | ---531K | ---- | ---- | ---- | ---- |
Earning before tax | -6.94%1.37B | -30.02%2.37B | -24.53%1.47B | 17.65%3.39B | 25.23%1.95B | 12.18%2.88B | 24.03%1.55B | 13.90%2.57B | 9.10%1.25B | 26.88%2.25B |
Tax | 5.53%-212.81M | 29.39%-307.59M | 19.81%-225.27M | -3.70%-435.59M | -10.44%-280.93M | -17.20%-420.07M | -23.15%-254.37M | -9.56%-358.42M | -17.69%-206.54M | -26.59%-327.14M |
After-tax profit from continuing operations | -7.20%1.15B | -30.12%2.06B | -25.32%1.24B | 20.03%2.95B | 28.13%1.66B | 11.36%2.46B | 24.20%1.3B | 14.64%2.21B | 7.55%1.05B | 26.93%1.93B |
Earning after tax | -7.20%1.15B | -30.12%2.06B | -25.32%1.24B | 20.03%2.95B | 28.13%1.66B | 11.36%2.46B | 24.20%1.3B | 14.64%2.21B | 7.55%1.05B | 26.93%1.93B |
Minority profit | 1.58%46.02M | -67.92%59.7M | -68.20%45.31M | 2.31%186.06M | 58.70%142.47M | 51.22%181.85M | 78.89%89.77M | 59.71%120.25M | 41.41%50.18M | 71.72%75.3M |
Profit attributable to shareholders | -7.53%1.11B | -27.57%2B | -21.31%1.2B | 21.45%2.76B | 25.86%1.52B | 9.06%2.28B | 21.44%1.21B | 12.80%2.09B | 6.27%995.84M | 25.60%1.85B |
Basic earnings per share | -7.41%0.25 | -27.87%0.44 | -18.18%0.27 | 19.61%0.61 | 22.22%0.33 | 10.87%0.51 | 22.73%0.27 | 12.20%0.46 | 4.76%0.22 | 24.24%0.41 |
Diluted earnings per share | -7.69%0.24 | -27.87%0.44 | 0.26 | 22.00%0.61 | 8.70%0.5 | 12.20%0.46 | 24.24%0.41 | |||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data